Once thought to be a rare, disabling disorder of psychogenic origin, Tourette's syndrome is now recognized as a chronic neurologic condition that is manageable in most patients. Individualized therapy is the key to helping patients achieve a productive and socially integrated life-style. This article discusses diagnostic criteria, effective management strategies, and promising new drug therapies.